Trial Profile
A phase 3, multicenter, open-label study of naldemedine in patients with non-malignant pain and opioid-induced constipation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Apr 2018
Price :
$35
*
At a glance
- Drugs Naldemedine (Primary)
- Indications Constipation
- Focus Adverse reactions
- Sponsors Shionogi
- 08 Jun 2016 New trial record